Möchten Sie immer auf dem neuesten Stand bleiben?

TAIWAN, Sept. 30, 2025 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio Ltd” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and...

Coty disclosed a surprise loss and weak guidance on Aug 20, 2025, citing market and consumer headwinds. Shares fell 21.6% to $3.81 the next day.

Jasper allegedly lacked proper controls over third-party manufacturing, overstating briquilimab’s prospects and misleading investors.

Fluor allegedly hid rising project costs, delays, and economic risks, making its FY25 guidance unreliable and overstating its risk strategy.

BOCA RATON, Fla., Sept. 30, 2025 (GLOBE NEWSWIRE) -- ADT Inc. (NYSE: ADT) (the “Company” or “ADT”), today announced that its indirect wholly owned subsidiary, The ADT Security Corporation, has...

Align is under investigation after missing Q2 estimates, cutting guidance, and seeing shares plunge nearly 37% on July 31, 2025.

Lantheus allegedly misled investors on Pylarify’s pricing and competitive risks, hiding that a 2025 price hike hurt its position and growth prospects.

SAN FRANCISCO, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Investors in MoonLake Immunotherapeutics (NASDAQ: MLTX) saw the price of their shares crater $55.75, or about 90%, after the company announced...

Agilon allegedly hid key details on its CEO’s abrupt exit and guidance withdrawal, causing a 27% stock drop and raising potential securities law concerns.

Fortinet allegedly misled on its firewall refresh cycle; Aug 6, 2025, it admitted limits, prompting a 22% stock drop.